Cargando…

Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides

BACKGROUND: The antibacterial activity of host defense peptides (HDP) is largely mediated by permeabilization of bacterial membranes. The lipid membrane of enveloped viruses might also be a target of antimicrobial peptides. Therefore, we screened a panel of naturally occurring HDPs representing diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinstraesser, Lars, Tippler, Bettina, Mertens, Janine, Lamme, Evert, Homann, Heinz-Herbert, Lehnhardt, Marcus, Wildner, Oliver, Steinau, Hans-Ulrich, Überla, Klaus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548510/
https://www.ncbi.nlm.nih.gov/pubmed/15656908
http://dx.doi.org/10.1186/1742-4690-2-2
_version_ 1782122360066801664
author Steinstraesser, Lars
Tippler, Bettina
Mertens, Janine
Lamme, Evert
Homann, Heinz-Herbert
Lehnhardt, Marcus
Wildner, Oliver
Steinau, Hans-Ulrich
Überla, Klaus
author_facet Steinstraesser, Lars
Tippler, Bettina
Mertens, Janine
Lamme, Evert
Homann, Heinz-Herbert
Lehnhardt, Marcus
Wildner, Oliver
Steinau, Hans-Ulrich
Überla, Klaus
author_sort Steinstraesser, Lars
collection PubMed
description BACKGROUND: The antibacterial activity of host defense peptides (HDP) is largely mediated by permeabilization of bacterial membranes. The lipid membrane of enveloped viruses might also be a target of antimicrobial peptides. Therefore, we screened a panel of naturally occurring HDPs representing different classes for inhibition of early, Env-independent steps in the HIV replication cycle. A lentiviral vector-based screening assay was used to determine the inhibitory effect of HDPs on early steps in the replication cycle and on cell metabolism. RESULTS: Human LL37 and porcine Protegrin-1 specifically reduced lentiviral vector infectivity, whereas the reduction of luciferase activities observed at high concentrations of the other HDPs is primarily due to modulation of cellular activity and/ or cytotoxicity rather than antiviral activity. A retroviral vector was inhibited by LL37 and Protegrin-1 to similar extent, while no specific inhibition of adenoviral vector mediated gene transfer was observed. Specific inhibitory effects of Protegrin-1 were confirmed for wild type HIV-1. CONCLUSION: Although Protegrin-1 apparently inhibits an early step in the HIV-replication cycle, cytotoxic effects might limit its use as an antiviral agent unless the specificity for the virus can be improved.
format Text
id pubmed-548510
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5485102005-02-11 Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides Steinstraesser, Lars Tippler, Bettina Mertens, Janine Lamme, Evert Homann, Heinz-Herbert Lehnhardt, Marcus Wildner, Oliver Steinau, Hans-Ulrich Überla, Klaus Retrovirology Research BACKGROUND: The antibacterial activity of host defense peptides (HDP) is largely mediated by permeabilization of bacterial membranes. The lipid membrane of enveloped viruses might also be a target of antimicrobial peptides. Therefore, we screened a panel of naturally occurring HDPs representing different classes for inhibition of early, Env-independent steps in the HIV replication cycle. A lentiviral vector-based screening assay was used to determine the inhibitory effect of HDPs on early steps in the replication cycle and on cell metabolism. RESULTS: Human LL37 and porcine Protegrin-1 specifically reduced lentiviral vector infectivity, whereas the reduction of luciferase activities observed at high concentrations of the other HDPs is primarily due to modulation of cellular activity and/ or cytotoxicity rather than antiviral activity. A retroviral vector was inhibited by LL37 and Protegrin-1 to similar extent, while no specific inhibition of adenoviral vector mediated gene transfer was observed. Specific inhibitory effects of Protegrin-1 were confirmed for wild type HIV-1. CONCLUSION: Although Protegrin-1 apparently inhibits an early step in the HIV-replication cycle, cytotoxic effects might limit its use as an antiviral agent unless the specificity for the virus can be improved. BioMed Central 2005-01-18 /pmc/articles/PMC548510/ /pubmed/15656908 http://dx.doi.org/10.1186/1742-4690-2-2 Text en Copyright © 2005 Steinstraesser et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Steinstraesser, Lars
Tippler, Bettina
Mertens, Janine
Lamme, Evert
Homann, Heinz-Herbert
Lehnhardt, Marcus
Wildner, Oliver
Steinau, Hans-Ulrich
Überla, Klaus
Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
title Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
title_full Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
title_fullStr Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
title_full_unstemmed Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
title_short Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
title_sort inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548510/
https://www.ncbi.nlm.nih.gov/pubmed/15656908
http://dx.doi.org/10.1186/1742-4690-2-2
work_keys_str_mv AT steinstraesserlars inhibitionofearlystepsinthelentiviralreplicationcyclebycathelicidinhostdefensepeptides
AT tipplerbettina inhibitionofearlystepsinthelentiviralreplicationcyclebycathelicidinhostdefensepeptides
AT mertensjanine inhibitionofearlystepsinthelentiviralreplicationcyclebycathelicidinhostdefensepeptides
AT lammeevert inhibitionofearlystepsinthelentiviralreplicationcyclebycathelicidinhostdefensepeptides
AT homannheinzherbert inhibitionofearlystepsinthelentiviralreplicationcyclebycathelicidinhostdefensepeptides
AT lehnhardtmarcus inhibitionofearlystepsinthelentiviralreplicationcyclebycathelicidinhostdefensepeptides
AT wildneroliver inhibitionofearlystepsinthelentiviralreplicationcyclebycathelicidinhostdefensepeptides
AT steinauhansulrich inhibitionofearlystepsinthelentiviralreplicationcyclebycathelicidinhostdefensepeptides
AT uberlaklaus inhibitionofearlystepsinthelentiviralreplicationcyclebycathelicidinhostdefensepeptides